2,163
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Psilocybin therapy for depression. A good trip?

ORCID Icon
Pages 1-2 | Received 19 Feb 2023, Accepted 19 Feb 2023, Published online: 13 Mar 2023

References

  • Bogenschutz, M. P., Ross, S., Bhatt, S., Baron, T., Forcehimes, A. A., Laska, E., et al. (2022). Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs. placebo in the treatment of adult patients with alcohol use disorder. JAMA Psychiatry, 79(10), 953-962. https://doi.org/10.1001/jamapsychiatry.2022.2096
  • Goodwin, G. M., Aaronson, S. T., Alvarez, O., Arden, P. C., Baker, A., Bennett, J. C., Bird, C., Blom, R. E., Brennan, C., Brusch, D., Burke, L., Campbell-Coker, K., Carhart-Harris, R., Cattell, J., Daniel, A., DeBattista, C., Dunlop, B. W., Eisen, K., Feifel, D., … Malievskaia, E. (2022). Single-dose psilocybin for a treatment-resistant episode of major depression. The New England Journal of Medicine, 387(18), 1637–1648. https://doi.org/10.1056/NEJMoa2206443
  • Grof, S. (1988). The adventure of self-discovery. State University of New York Press.
  • Hasler, F., Bourquin, D., Brenneisen, R., Bar, T., & Vollenweider, F. X. (1997). Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man. Pharmaceutica Acta Helvetiae, 72(3), 175–184. https://doi.org/10.1016/s0031-6865(97)00014-9
  • Rucker, J. J., Jelen, L. A., Flynn, S., Frowde, K. D., & Young, A. H. (2016). Psychedelics in the treatment of unipolar mood disorders: A systematic review. Journal of Psychopharmacology, 30(12), 1220–1229. https://doi.org/10.1177/0269881116679368
  • Vargas, Maxemiliano V. Dunlap, Lee E. Dong, Chunyang Carter, Samuel J. Tombari, Robert J. Jami, Shekib A. Cameron, Lindsay P. Patel, Seona D. Hennessey, Joseph J. Saeger, Hannah N. McCorvy, John D. Gray, John A. Tian, Lin Olson, David E. (2020). Transient stimulation with psychoplastogens is sufficient to initiate neuronal growth. ACS Pharmacology & Translational Science, 6633, 700-706. https://doi.org/10.1021/acsptsci.0c00065
  • Vollenweider, F. X., & Kometer, M. (2010). The neurobiology of psychedelic drugs: Implications for the treatment of mood disorders. Nature Reviews. Neuroscience, 11(9), 642–651. https://doi.org/10.1038/nrn2884

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.